Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36,685 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu Q, Wang X, Chen Q, Zou Y, Xu X, Li T, Yu C, Zhu F, Zhang KE, Jia J, Liu Y. Wu Q, et al. Among authors: chen q. Drug Des Devel Ther. 2020 Oct 12;14:4221-4230. doi: 10.2147/DDDT.S253078. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33116410 Free PMC article. Clinical Trial.
Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose Administration.
Zhang YF, Liu YM, Yu C, Wang YT, Zhan Y, Liu HY, Zou JJ, Jia JY, Chen Q, Zhong DF. Zhang YF, et al. Among authors: chen q. Clin Ther. 2021 Feb;43(2):396-409. doi: 10.1016/j.clinthera.2020.12.012. Epub 2021 Jan 14. Clin Ther. 2021. PMID: 33454124 Clinical Trial.
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects.
Qian H, Chen Q, Liang L, Zou Y, Pu H, Xin L, Song R, Li T, Zhu H, Wang Y, Tian G, Shen J, Jiang H, Yu C, Wang Z, Jia J. Qian H, et al. Among authors: chen q. Drug Des Devel Ther. 2021 Jul 6;15:2947-2959. doi: 10.2147/DDDT.S308610. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34262260 Free PMC article. Clinical Trial.
A Randomized, Double-Blind, Parallel Controlled, Single-Dose Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of the Infliximab Biosimilar CMAB008 and the Reference Product in Healthy Chinese Male Subjects.
Zhou R, Chen Q, Hou S, Guo H, Li J, Qian W, Wang H, Ou L, Chen X, Jiang F, Jia J. Zhou R, et al. Among authors: chen q, chen x. Clin Pharmacol Drug Dev. 2022 Sep;11(9):1028-1035. doi: 10.1002/cpdd.1135. Epub 2022 Jul 2. Clin Pharmacol Drug Dev. 2022. PMID: 35778977 Clinical Trial.
Mass balance, metabolism, and pharmacokinetics of [14C]amdizalisib, a clinical-stage novel oral selective PI3Kδ inhibitor for the treatment of non-hodgkin's lymphoma, in healthy Chinese volunteers.
Zhao CY, Zhang LJ, Sun C, Yu CY, Wang J, Sai Y, Su WG, Chen Q, Wang W, Jia JY, Liu GY, Liu YM. Zhao CY, et al. Among authors: chen q. Front Pharmacol. 2024 Nov 15;15:1478234. doi: 10.3389/fphar.2024.1478234. eCollection 2024. Front Pharmacol. 2024. PMID: 39619614 Free PMC article.
36,685 results
You have reached the last available page of results. Please see the User Guide for more information.